RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Elaine Gay

Elaine Gay

Research Pharmacologist


PhD, Neurobiology, University of North Carolina
BS, Biology, Furman University

Elaine Gay, Ph.D., is a neuropharmacologist focused on understanding the structure and function of G-protein coupled receptors (GPCR) and ligand-gated ion channels. 

Her research interests include functional selectivity (ligand-bias) of novel drugs at GPCRs, in particular dopamine receptors and orphan receptors. She studies the unique signaling properties of functionally selective compounds and how varied cellular signaling profiles translate into behavioral and therapeutic outcomes across neurobiological disorders.

Dr. Gay is also investigating the structure and physiology of neuronal nicotinic receptors and their role in Alzheimer’s disease and addiction. 

Dr. Gay is involved in cell-based assay development and lead optimization of new compounds for GPCRs and ion channels. She has experience in characterization of novel ligand/receptor interactions through receptor binding studies and multiple GPCR functional assays. Dr. Gay has expertise in electrophysiological techniques, including two-electrode voltage clamp, manual patch clamp, and automated electrophysiology. She has conducted experiments on microelectrode array platforms for assessment of integrated cardiac signaling. 

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics